TRIXEO AEROSPHERE is a prescription medication used in the management of chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. It is a combination inhaler that contains three active ingredients: budesonide, a corticosteroid that reduces inflammation; glycopyrronium, a long-acting muscarinic antagonist (LAMA) that helps to relax the muscles around the airways; and formoterol, a long-acting beta2-adrenergic agonist (LABA) that helps to open the airways. Together, these components work synergistically to improve breathing, prevent symptoms such as wheezing, coughing, and shortness of breath, and reduce the number and severity of exacerbations in individuals with COPD. TRIXEO AEROSPHERE is administered via a metered-dose inhaler, making it convenient for patients to use as part of their daily COPD management regimen.